Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Oncology

Lung/Thoracic Oncology

Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) – A decision-making analysis amongst European lung cancer experts

Lung Cancer | Jul 22, 2020 Lung/Thoracic Oncology

A phase 3, randomized, double-blind, placebo-controlled, multicenter study of fruquintinib in Chinese patients with advanced nonsquamous non-small-cell lung cancer – The FALUCA study

Lung Cancer | Jul 22, 2020 Lung/Thoracic Oncology

Association of molecular characteristics with survival in advanced non-small cell lung cancer patients treated with checkpoint inhibitors

Lung Cancer | Jul 22, 2020 Lung/Thoracic Oncology

Cardiovascular mortality and morbidity following radical radiotherapy for lung cancer: Is cardiovascular death under-reported?

Lung Cancer | Jul 22, 2020 Lung/Thoracic Oncology

Comparison of prognostic impact of lymphovascular invasion in stage IA non- small cell lung cancer after lobectomy vs sublobar resection: A propensity score-matched analysis

Lung Cancer | Jul 22, 2020 Lung/Thoracic Oncology

Clinical characteristics and prognostic factors of surgically resected combined small cell lung cancer: A retrospective study

Lung Cancer | Jul 22, 2020 Lung/Thoracic Oncology

Effectiveness and prognostic factors of first-line crizotinib treatment in patients with ROS1-rearranged non-small cell lung cancer: A multicenter retrospective study

Lung Cancer | Jul 20, 2020 Lung/Thoracic Oncology

Severe OSA associated with higher risk of mortality in stage III and IV lung cancer

Journal of Clinical Sleep Medicine | Jul 20, 2020 Lung/Thoracic Oncology

Predictors of lung cancer screening utilization in a population-based survey

Journal of the American College of Radiology | Jul 20, 2020 Lung/Thoracic Oncology

Association between diabetes mellitus and lung cancer: Meta‐analysis

European Journal of Clinical Investigation | Jul 17, 2020 Lung/Thoracic Oncology

« Prev 1 … 48 49 50 51 52 … 149 Next »

Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) – A decision-making analysis amongst European lung cancer experts

A phase 3, randomized, double-blind, placebo-controlled, multicenter study of fruquintinib in Chinese patients with advanced nonsquamous non-small-cell lung cancer – The FALUCA study

Association of molecular characteristics with survival in advanced non-small cell lung cancer patients treated with checkpoint inhibitors

Cardiovascular mortality and morbidity following radical radiotherapy for lung cancer: Is cardiovascular death under-reported?

Comparison of prognostic impact of lymphovascular invasion in stage IA non- small cell lung cancer after lobectomy vs sublobar resection: A propensity score-matched analysis

Clinical characteristics and prognostic factors of surgically resected combined small cell lung cancer: A retrospective study

Effectiveness and prognostic factors of first-line crizotinib treatment in patients with ROS1-rearranged non-small cell lung cancer: A multicenter retrospective study

Severe OSA associated with higher risk of mortality in stage III and IV lung cancer

Predictors of lung cancer screening utilization in a population-based survey

Association between diabetes mellitus and lung cancer: Meta‐analysis

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

Gut Health Disorders and its Management

Awareness for COPD: MCQ challenge

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) – A decision-making analysis amongst European lung cancer experts

A phase 3, randomized, double-blind, placebo-controlled, multicenter study of fruquintinib in Chinese patients with advanced nonsquamous non-small-cell lung cancer – The FALUCA study

Association of molecular characteristics with survival in advanced non-small cell lung cancer patients treated with checkpoint inhibitors

Cardiovascular mortality and morbidity following radical radiotherapy for lung cancer: Is cardiovascular death under-reported?

Comparison of prognostic impact of lymphovascular invasion in stage IA non- small cell lung cancer after lobectomy vs sublobar resection: A propensity score-matched analysis

Clinical characteristics and prognostic factors of surgically resected combined small cell lung cancer: A retrospective study

Effectiveness and prognostic factors of first-line crizotinib treatment in patients with ROS1-rearranged non-small cell lung cancer: A multicenter retrospective study

Severe OSA associated with higher risk of mortality in stage III and IV lung cancer

Predictors of lung cancer screening utilization in a population-based survey

Association between diabetes mellitus and lung cancer: Meta‐analysis

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

Gut Health Disorders and its Management

Awareness for COPD: MCQ challenge

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Select Specialty

Select Topic